Eli Lilly and Co
DUS:LLY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Eli Lilly and Co
DUS:LLY
|
US |
|
Abb Ltd
MIL:1ABB
|
CH |
|
S
|
SoftBank Group Corp
OTC:SFTBF
|
JP |
|
S
|
Saipem SpA
F:SPEA
|
IT |
|
C
|
Chevron Corp
DUS:CHV
|
US |
|
3
|
3M Co
XHAM:MMM
|
US |
|
P
|
Philip Morris International Inc
XMUN:4I1
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LLY's stock price target?
Price Target
1 188.68
EUR
According to Wall Street analysts, the average 1-year price target for 
LLY is 1 188.68 EUR with a low forecast of 778.47 EUR and a high forecast of 1 452.93 EUR.
What is the Revenue forecast for Eli Lilly and Co?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is 12%.
What is the Gross Profit forecast for Eli Lilly and Co?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 8 years is 12%.
What is the Operating Income forecast for Eli Lilly and Co?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 8 years is 15%.
What is the Pre-Tax Income forecast for Eli Lilly and Co?
Projected CAGR
33%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 33%.
What is the Net Income forecast for Eli Lilly and Co?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 8 years is 17%.